| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3245416
Max Phase: Preclinical
Molecular Formula: C28H42N4O2
Molecular Weight: 466.67
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: N=C(N)c1ccc(OCCCCCCCCCCCCCCOc2ccc(C(=N)N)cc2)cc1
Standard InChI: InChI=1S/C28H42N4O2/c29-27(30)23-13-17-25(18-14-23)33-21-11-9-7-5-3-1-2-4-6-8-10-12-22-34-26-19-15-24(16-20-26)28(31)32/h13-20H,1-12,21-22H2,(H3,29,30)(H3,31,32)
Standard InChI Key: UZAMQMRZMCQQJE-UHFFFAOYSA-N
Associated Targets(non-human)
Acrosin 53 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 466.67 | Molecular Weight (Monoisotopic): 466.3308 | AlogP: 6.39 | #Rotatable Bonds: 19 |
| Polar Surface Area: 118.20 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
| #RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: | CX Basic pKa: 12.13 | CX LogP: 6.32 | CX LogD: 1.50 |
| Aromatic Rings: 2 | Heavy Atoms: 34 | QED Weighted: 0.11 | Np Likeness Score: -0.10 |
References
| 1. Parrish RF, Straus JW, Paulson JD, Polakoski KL, Tidwell RR, Geratz JD, Stevens FM.. (1978) Structure-activity relationships for the inhibition of acrosin by benzamidine derivatives., 21 (11): [PMID:722718] [10.1021/jm00209a008] |
Source
Source(1):